-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Pediatrix Medical Group, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Pediatrix Medical Group, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $686K, a 65.8% decline year-over-year.
- Pediatrix Medical Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $3.24M.
- Pediatrix Medical Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$22.8M, a 27.1% increase from 2021.
- Pediatrix Medical Group, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$31.2M, a 186% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)